Market Outlook Snapshot Market Dynamics Regional Forecast Country Insights Segment Analysis Competitive Landscape Industry News report.faq_name
On This Report

Cannabidiol (CBD) Pet Market Size & Forecasts 2026-2035, By Segments (Product Type, Pet Type, Distribution Channel, Application), Growth Opportunities, Innovation Landscape, Regulatory Shifts, Strategic Regional Insights (U.S., Japan, China, South Korea, UK, Germany, France), and Competitive Dynamics (Charlotte’s Web, Pet Releaf, Medterra, Honest Paws, Joy Organics)

Report ID: FBI 20579| Published Date: Dec-2025| Format: PDF, Excel
MARKET OUTLOOK

Market Size and Growoth Outlook

Cannabidiol Pet Market size is projected to grow steadily from USD 925.77 million in 2025 to USD 5.1 billion by 2035, demonstrating a CAGR exceeding 18.6% through the forecast period (2026-2035). The 2026 revenue is estimated at USD 1.08 billion.

Base Year Value (2025)
USD 925.77 Million
CAGR (2026-2035)
18.6%
Forecast Year Value (2035)
USD 5.1 Billion
Historical Data Period
2022-2025
Largest Region
North America
Forecast Period
2026-2035

Get more details on this report

Request Free Sample Report
SNAPSHOT

Cannabidiol (CBD) Pet Market Intelligence Snapshot

Regional Market Dynamics

Segment Momentum

Market Expansion Drivers

Leading Market Participants

FORECAST SNAPSHOT

Global Market Forecast Snapshot

Market Outlook

Regional and Segment Outlook

MARKET DYNAMICS

Market Growth Drivers and Industry Trends

Rising Pet Ownership and Demand for Wellness Supplements

The cannabidiol (CBD) pet market is experiencing significant growth driven by the rising trend in pet ownership and an increasing consumer focus on wellness supplements. As more households adopt pets, particularly during the pandemic, the demand for health-oriented products has surged. According to the American Pet Products Association, pet ownership in the U.S. reached an all-time high, with nearly 70% of households owning a pet. This shift reflects a broader cultural inclination towards treating pets as family members, leading to heightened interest in products that enhance their well-being. Established players and new entrants have the opportunity to innovate by developing targeted CBD formulations that cater to specific health needs, such as anxiety relief and joint support, thus aligning with consumer preferences for holistic pet care.

Expansion of CBD Regulatory Approvals in Pet Products

The evolution of the cannabidiol (CBD) pet market is significantly shaped by the expansion of regulatory approvals for CBD-infused products. Recent advancements, such as the U.S. Food and Drug Administration's (FDA) acknowledgment of the need for a regulatory framework for CBD in pet products, signal a growing acceptance of these offerings. This regulatory clarity not only enhances consumer confidence but also encourages investment in research and development by established companies like PetSmart and new entrants looking to capture market share. Companies that navigate these regulatory landscapes effectively can leverage their compliance as a competitive advantage, fostering trust among pet owners and differentiating their products in a crowded marketplace.

Increasing Consumer Preference for Natural/Organic Pet Care

The cannabidiol (CBD) pet market is further bolstered by a rising consumer preference for natural and organic pet care products. Pet owners are increasingly seeking out products with clean ingredient lists, driven by a broader trend towards health and sustainability. A survey by the Pet Industry Distributors Association found that 70% of pet owners are willing to pay a premium for natural products. This shift presents significant opportunities for brands that prioritize transparency and sustainability in their sourcing and manufacturing processes. Companies that emphasize organic CBD sourcing and environmentally friendly practices can attract a loyal customer base, positioning themselves as leaders in the evolving pet care landscape.

Industry Restraints:

Product Quality and Standardization Challenges

The cannabidiol (CBD) pet market is significantly hampered by the lack of standardized product quality and formulation guidelines. This inconsistency undermines consumer trust, as pet owners are often unsure about the efficacy and safety of CBD products for their animals. According to the American Kennel Club, the absence of regulatory clarity has led to a wide variance in product quality, with some products containing negligible amounts of CBD or harmful additives. This not only affects consumer confidence but also creates operational inefficiencies for companies that must navigate a patchwork of state regulations and market expectations. Established companies like Pet Releaf have acknowledged the need for transparency and quality assurance, yet the lack of uniform standards continues to challenge both incumbents and new entrants in establishing credibility and market share. As the market matures, the pressure for standardized quality will likely intensify, pushing companies to adopt rigorous testing protocols and transparency practices to gain consumer trust.

Market Perception and Consumer Education Barriers

Consumer hesitation remains a critical restraint in the CBD pet market, largely stemming from misconceptions about cannabidiol and its effects on pets. Many pet owners are still unfamiliar with CBD's potential benefits, often viewing it with skepticism due to its association with marijuana. A survey by the Veterinary Information Network indicates that a significant portion of pet owners are unaware of the differences between CBD and THC, leading to reluctance in purchasing these products. This lack of understanding poses a substantial barrier to market growth, as it restricts the customer base primarily to those already informed about the benefits of CBD. For companies like Honest Paws, which actively engage in educational campaigns, the challenge lies in overcoming this knowledge gap while competing against a landscape of misinformation. Moving forward, effective consumer education strategies will be essential for market participants to expand their reach and improve adoption rates, particularly as more scientific research emerges to validate the benefits of CBD for pets.

Growth Driver Impact on CAGR Regulatory Influence Geographic Relevance Adoption Rate Impact Timeline
Rising pet ownership and demand for wellness supplements 3.00% Short term (≤ 2 yrs) North America, Europe (spillover: Asia Pacific) Medium Fast
Expansion of CBD regulatory approvals in pet products 2.00% Medium term (2–5 yrs) North America, Europe (spillover: Latin America) High Moderate
Increasing consumer preference for natural/organic pet care 1.50% Long term (5+ yrs) Europe, Asia Pacific (spillover: North America) Medium Slow
CUSTOM RESEARCH

Unlock insights tailored to your business with our bespoke market research solutions.

Click to get your customized report now.

Request Customization →
REGIONAL FORECAST

Regional Demand Dynamics

Polymer Modified Bitumen Market
Largest Region
North America
46.35% Market Share in 2025

North America Market Statistics:

The North America region represented more than 46.35% of the global cannabidiol (CBD) pet market in 2025, establishing itself as the largest and fastest-growing segment. This dominance can be attributed to high pet care spending, which reflects a cultural shift towards treating pets as family members, thus increasing demand for premium products, including CBD-infused pet items. Additionally, evolving consumer preferences favor natural and holistic solutions for pet wellness, driving a surge in CBD product adoption. Regulatory frameworks in the U.S. have become increasingly supportive, allowing for innovation and market expansion, as seen in the guidance from the U.S. Food and Drug Administration. These factors create a robust environment for growth, positioning North America as a significant opportunity hub in the cannabidiol (CBD) pet market.

The United States anchors the North American market for the cannabidiol (CBD) pet industry, showcasing a unique interplay of consumer demand and regulatory support. The growing trend toward high-quality pet care is evident as American pet owners increasingly seek out CBD products for their health benefits, with organizations like the American Veterinary Medical Association highlighting the potential therapeutic effects of CBD on pets. Furthermore, the competitive landscape is intensifying, with companies such as Charlotte's Web Holdings, Inc. actively expanding their product lines to cater to this burgeoning market. As a result, the U.S. not only leads in market share but also sets the pace for innovation and consumer engagement strategies, reinforcing North America's overall leadership in the cannabidiol (CBD) pet market.

Europe Market Analysis:

Europe emerged as the fastest-growing region in the cannabidiol (CBD) pet market, registering rapid growth with a robust CAGR of 20%. This growth is primarily driven by increasing pet wellness trends, reflecting a significant shift in consumer preferences towards natural and holistic health solutions for pets. As pet owners become more aware of the therapeutic benefits of CBD, demand for these products is surging, leading to a broader acceptance of CBD-infused pet products across various demographics. This trend is further supported by evolving regulatory frameworks that are becoming more favorable towards CBD use, allowing for greater market penetration and innovation.

Germany plays a pivotal role in the European cannabidiol (CBD) pet market, characterized by a strong inclination towards premium pet products. The growing pet wellness trends are particularly pronounced here, with consumers increasingly seeking out CBD solutions for their pets' health issues, such as anxiety and chronic pain. Recent data from the German Pet Products Association indicates that over 30% of pet owners are now considering CBD products as part of their pets' wellness regimen. This heightened consumer awareness is complemented by a supportive regulatory environment, as the Federal Institute for Risk Assessment has been proactive in establishing guidelines for CBD use, fostering a competitive landscape where innovation thrives. As a result, Germany's market dynamics are likely to catalyze further growth opportunities within the region.

France, another major player in the European cannabidiol (CBD) pet market, showcases a unique landscape where pet humanization trends significantly influence consumer behavior. The increasing focus on pet wellness trends has led to a surge in demand for CBD products, particularly among urban pet owners who prioritize their pets' health and well-being. A recent study by the French Federation of Pet Industry reported that nearly 25% of pet owners have purchased CBD products in the past year, indicating a growing acceptance and desire for natural alternatives. Additionally, France's regulatory framework is evolving, with recent legislation allowing for the legal sale of CBD products, thus enhancing market accessibility. This favorable environment positions France as a strategic hub for CBD innovation and distribution in Europe, aligning with the region's overall growth trajectory in the cannabidiol (CBD) pet market.

APAC Market Trends:

The Asia Pacific region has maintained a notable presence in the cannabidiol (CBD) pet market, reflecting both a significant share and high potential for future growth. This region's importance is underscored by increasing pet ownership rates, shifting consumer preferences toward natural and holistic pet care solutions, and a growing awareness of the health benefits associated with CBD products. Recent trends indicate a robust demand for CBD-infused pet products, driven by pet owners' desire for alternative therapies and wellness options. According to the Asia Pacific Cannabis Report by Prohibition Partners, the market is expected to thrive as regulatory frameworks evolve, particularly in countries like Japan and China, where a cultural shift toward pet wellness is evident. The region's economic resilience and technological advancements in product formulation and distribution further enhance its attractiveness to investors and market players, positioning it as a key area for strategic opportunities in the CBD pet segment.

Japan plays a pivotal role in the Asia Pacific cannabidiol (CBD) pet market, characterized by a strong consumer inclination toward premium pet products and wellness solutions. The Japanese market has experienced moderate growth driven by increasing awareness of CBD's therapeutic properties for pets, coupled with a regulatory landscape that is gradually becoming more favorable. A report by the Ministry of Agriculture, Forestry and Fisheries of Japan highlights a growing acceptance of CBD products among pet owners, reflecting a broader trend towards natural remedies in pet care. Furthermore, local companies like Green Zone and Cannacare are innovating with CBD formulations tailored to Japanese pets, showcasing a competitive landscape that is responding to consumer demands. This dynamic positioning not only enhances Japan's market stature but also contributes to the overall growth of the Asia Pacific CBD pet market, presenting significant opportunities for investment and expansion.

China is emerging as a key player in the cannabidiol (CBD) pet market within the Asia Pacific region, driven by its vast pet population and an increasing trend toward premiumization in pet care. The Chinese market is witnessing a surge in demand for CBD products, fueled by shifting consumer attitudes that prioritize pet health and wellness. The National Health Commission of the People's Republic of China has indicated a positive outlook on the integration of natural ingredients in pet products, aligning with growing consumer preferences for organic and holistic options. Companies such as Canopy Growth and Pet Releaf are making strategic inroads into the Chinese market, leveraging local partnerships to navigate regulatory complexities and enhance product accessibility. This growth trajectory positions China as a critical contributor to the regional CBD pet market, indicating substantial opportunities for stakeholders looking to capitalize on the evolving landscape of pet health and wellness.

Parameter North America Asia Pacific Europe Latin America MEA
Innovation Hub i Scale Nascent Developing Advanced
Cost-Sensitive Region i Scale Low Medium High
Regulatory Environment i Scale Restrictive Neutral Supportive
Demand Drivers i Scale Weak Moderate Strong
Development Stage i Scale Emerging Developing Developed
Adoption Rate i Scale Low Medium High
New Entrants / Startups i Scale Sparse Moderate Dense
Macro Indicators i Scale Weak Stable Strong
COUNTRY INSIGHTS

Key Country Insights

United States 🇺🇸

Veterinary Wellness Adoption

The U.S. CBD pet market is shaped by expanding premium pet care offerings and growing interest in hemp-derived wellness products for companion animals. Companies emphasize product quality, veterinary engagement, and transparent ingredient sourcing to strengthen consumer confidence.

Germany 🇩🇪

Regulated Product Standards

Germany prioritizes compliance with evolving regulations and scientifically supported product formulations in the CBD pet market. Manufacturers focus on controlled distribution channels and quality assurance to meet expectations from retailers, veterinarians, and pet owners.

Japan 🇯🇵

Functional Pet Care Focus

Japan integrates CBD pet products into the broader trend of functional pet wellness, with attention to aging companion animals and daily health support. Brands invest in carefully formulated products that align with consumer preference for safe and premium pet care solutions.

South Korea 🇰🇷

Premium Companion Nutrition

South Korea is expanding premium CBD pet offerings alongside rising demand for specialized nutrition and wellness products. Market participants emphasize innovative formulations, digital retail engagement, and consumer education to encourage responsible product adoption.

France 🇫🇷

Natural Care Positioning

France favors CBD pet products positioned around natural wellness and responsible ingredient selection. Suppliers work to align product development with evolving regulatory expectations while expanding premium options through specialty pet retail channels.

Italy 🇮🇹

Boutique Wellness Expansion

Italy supports growth in CBD pet products through specialty retailers and premium pet care brands targeting wellness-conscious owners. Companies prioritize product differentiation, trusted sourcing, and educational marketing to encourage wider acceptance.

SEGMENT ANALYSIS

Segment Leadership and Growth Trends

Cannabidiol (CBD) Pet Market Share (%), Product Type, 2025

Supplements
Therapeutics

Go beyond the chart, access full insights & data tables

Request Free Sample Report

Analysis by Product Type

The cannabidiol (CBD) pet market for supplements dominated the segment with a significant 61.11% share in 2025. This leadership is primarily driven by preventive wellness trends that favor daily non-pharmaceutical support for pets, reflecting a growing consumer preference for holistic health solutions. The rise in pet ownership and the increasing awareness of CBD's potential health benefits have further fueled demand, as pet owners seek natural alternatives to traditional medications. Companies like Charlotte's Web have emphasized the importance of transparency and quality in their product offerings, aligning with consumer priorities for sustainability and efficacy. This segment presents strategic advantages for both established firms and emerging players, enabling them to innovate and cater to an increasingly health-conscious market. With ongoing developments in regulatory frameworks and an expanding body of research supporting CBD's benefits, the supplement segment is expected to remain relevant as pet owners continue to prioritize wellness.

Analysis by Pet Type

The cannabidiol (CBD) pet market for dogs captured over 63.05% share of the segment in 2025. This substantial share is largely attributed to the high prevalence of joint and anxiety issues in aging canine populations, prompting pet owners to seek effective solutions. As the demographic of pet owners shifts towards younger generations who prioritize pet health and well-being, the demand for CBD products tailored for dogs has surged. Companies like Pet Releaf have responded by developing targeted formulations that address specific health concerns, reflecting a keen understanding of customer preferences. This segment offers significant opportunities for brands to differentiate themselves through specialized products and marketing strategies. Given the increasing focus on pet health and the growing acceptance of CBD, the dog segment is poised to maintain its prominence in the market for the foreseeable future.

Analysis by Distribution Channel

The cannabidiol (CBD) pet market in e-commerce held a commanding 41.2% share in 2025. This dominance can be attributed to the convenience and discreet purchasing options that e-commerce provides for specialized wellness items, appealing to a broad base of tech-savvy consumers. The shift towards online shopping has been accelerated by changing consumer behaviors and the need for accessible health solutions for pets, with platforms like Chewy leading the way in product availability and customer engagement. Additionally, the digital transformation in retail has enabled brands to leverage data analytics for targeted marketing, enhancing customer experiences. This segment creates strategic advantages for both established firms looking to expand their online presence and new entrants aiming to capture niche markets. As e-commerce continues to evolve with advancements in logistics and customer service, it is expected to remain a vital channel for the CBD pet market.

Segment Sub-Segment Largest Segment Fastest Growing
Product Type Therapeutics, Supplements
Pet Type Cats, Dogs, Other pet types
Distribution Channel Pet specialty stores, CBD stores, E-commerce, Other distribution channels
Application Pain management, Anxiety and stress relief, Joint health and mobility, Skin and allergies, Other applications
Competitive Landscape

Competitive Landscape and Market Positioning

Key players in the cannabidiol (CBD) pet market include Charlotte’s Web, Pet Releaf, Medterra, Honest Paws, Joy Organics, HolistaPet, Canna-Pet, Green Roads, CBD American Shaman, and King Kanine. These companies have established significant brand recognition and consumer trust through their commitment to quality and transparency in product formulations. Their prominence is further enhanced by strategic marketing initiatives and a focus on educating pet owners about the benefits of CBD for pets. This collective influence positions them as leaders in a rapidly evolving market, where consumer awareness and demand for natural wellness solutions continue to grow.

The competitive landscape in the cannabidiol (CBD) pet market is characterized by a dynamic interplay of innovation and strategic collaboration among the top players. Many of these companies are actively enhancing their portfolios through the introduction of new product lines that cater to specific pet needs, such as anxiety relief or joint support. Additionally, partnerships with veterinary professionals and pet wellness organizations are becoming increasingly common, allowing these firms to strengthen their credibility and expand their reach. This environment fosters a culture of innovation, where companies are not only competing on product efficacy but also on the educational resources they provide to consumers, thus shaping the overall market positioning.

Strategic / Actionable Recommendations for Regional Players

In North America, players could benefit from forging alliances with veterinary clinics and pet health influencers to enhance credibility and reach. Engaging in community outreach programs that educate pet owners about the therapeutic benefits of CBD may also create a loyal customer base.

For the Asia Pacific region, exploring partnerships with local distributors and retailers can facilitate market entry and expansion. Emphasizing the unique health benefits of CBD products tailored to regional pet care preferences may resonate well with consumers, catering to specific cultural attitudes towards pet wellness.

In Europe, leveraging advancements in formulation technologies could help regional players differentiate their offerings. Collaborations with research institutions to validate product efficacy through scientific studies may enhance consumer trust and drive adoption in a market that is becoming increasingly discerning.

Company Market Share Company Revenue Revenue CAGR (%) Product Portfolio Geographic Presence Innovation / R&D Focus Strategic Developments
No companies available.
🔒 This section is available as a standalone purchase. Buy only the data you need. Inquire Before Buying
Industry News

Industry Development/News

Company Name Date Key Development
Report Customization

Explore This Report

Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.

1 report.custom report.segments 2 Custom TOC 3 Related Reports

Cannabidiol (CBD) Pet Market — Custom Segments

Segment Sub-Segment
No segment data available.

Cannabidiol (CBD) Pet Market — report.custom

Custom Chapter Custom Details
No custom TOC data available.

Need a different cut of the data?

Request Custom Research
report.faq_name

How much is the cannabidiol (CBD) pet market worth?

The market size of cannabidiol pet in 2026 is calculated to be USD 1.08 billion.

How is the cannabidiol pet industry expected to grow over the next 10 years?

Cannabidiol Pet Market size is expected to advance from USD 925.77 million in 2025 to USD 5.1 billion by 2035, registering a CAGR of more than 18.6% across 2026-2035.

Which territory demonstrates the strongest presence in the cannabidiol (CBD) pet market?

North America region garnered more than 46.35% market share in 2025, led by high pet care spending.

Where has the cannabidiol pet sector recorded the sharpest year-over-year increase?

Europe region will observe more than 20% CAGR between 2026 and 2035, driven by growing pet wellness trends.

Why does supplements sub-segment dominate the product type segment of cannabidiol (CBD) pet sector?

The supplements segment accounted for a 61.11% share of the market in 2025, fueled by preventive wellness trends favoring daily non-pharmaceutical support.

How does dogs segment fare in the cannabidiol (CBD) pet industry?

In 2025, the dogs segment led the cannabidiol pet market with a 63.05% share, driven by the high prevalence of joint and anxiety issues in aging canine populations.

What share does E-commerce segment hold in the cannabidiol (CBD) pet sector as of 2025?

In 2025, the E-commerce segment held a 41.2% share of the market, propelled by convenience and discreet purchasing for specialized wellness items.

What are the key competitors in the cannabidiol pet landscape?

Top companies in the cannabidiol pet market comprise Charlotte’s Web (United States), Pet Releaf (United States), Medterra (United States), Honest Paws (United States), Joy Organics (United States), HolistaPet (United States), Canna-Pet (United States), Green Roads (United States), CBD American Shaman (United States), King Kanine (United States).
Testimonials

Our Clients

"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."

Quality Assurance Manager

"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."

R&D Manager

"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."

Senior Marketing Manager
THE RESEARCH BEHIND THIS REPORT

Our Research Team & Methodology

Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.

THIS REPORT'S RESEARCH VERTICAL

Research Team Overview

♢
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.

Prepared by the Healthcare & Medical Devices Research Team

10+
Industry Verticals
100+
Countries Analyzed
5–7
Days Standard
Delivery
12k+
Research Reports
Published
On-
Demand
Customized Research
Available
6
Months Analyst
Support
PDF + XLS
Report Deliverables

Trust & Compliance

☷D&B D-U-N-S
♢GDPR & CCPA Compliant
♙ISO 9001 Certified (ISO 9001:2015)
♙SSL Encryption
▭Secure Payments
✓Confidential Handling

Research Domains

10 coverage areas
Medical Devices & Equipment Diagnostic Imaging Clinical Diagnostics Digital Health & Telemedicine Patient Monitoring Systems Surgical & Minimally Invasive Technologies Healthcare IT & Data Systems Biotechnology & Life Sciences Pharmaceutical Technologies Healthcare Delivery & Services

Research Intelligence

Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts

Research Workflow & Quality Assurance

📥
01

Data Collection

Verified information gathered through primary and secondary research.

🔍
02

Data Triangulation

Cross-validation using multiple independent data sources.

📈
03

Forecast Modelling

Market estimates developed using historical trends and analytical models.

👨‍💼
04

Analyst Validation

Findings reviewed by domain experts for accuracy and consistency.

📝
05

Editorial & Quality Review

Final editorial, quality, and compliance checks before publication.

✅
06

Final Publication

Released after successful completion of the internal review process.

Report Coverage

📊 Market Assessment

  • Market Size & Forecast
  • Market Segmentation
  • Regional Analysis
  • Growth Drivers & Challenges
  • Market Dynamics

🏢 Competitive Intelligence

  • Competitive Landscape
  • Company Profiles
  • Competitive Benchmarking
  • Mergers & Acquisitions
  • Market Share Analysis or Key Company Strategies

🔍 Strategic Analysis

  • Value Chain Analysis
  • Porter's Five Forces
  • PESTLE Analysis
  • Pricing Trends
  • Supply-Demand Analysis

🚀 Future Outlook

  • Technology Landscape
  • Regulatory Landscape
  • Investment & Funding Landscape
  • Emerging Opportunities
  • Future Market Outlook

Have a question about this report or need a custom scope?

Request Customization
License

Select License Type

Single User
US$ 4,250
Buy Now
Corporate User
US$ 6,150
Buy Now

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →